SCHEMBL9813566

SCHEMBL9813566

Cc1cccc(C)c1NC(=O)/C=C1\SCC(=O)N1C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMD14 O00487 1/20 0.61
▸ ALDH1A1 P00352 4/20 0.60
▸ TDP1 Q9NUW8 1/20 0.60
▸ POLB P06746 1/20 0.40
▸ KMT2A Q03164 5/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ ATM Q13315 1/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ MAPT P10636 5/20 0.37
▸ HTT P42858 3/20 0.37
▸ ALOX15 P16050 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ LMNA P02545 2/20 0.36
▸ PKM P14618 1/20 0.36
▸ GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9813569 1.00 PSMD14 (0.61) PSMD14ALDH1A1TDP1POLBKMT2A
Ralitoline SCHEMBL635346 0.92 PSMD14 (0.55) PSMD14ALDH1A1TDP1GAA
Ralitoline SCHEMBL9813595 0.92 PSMD14 (0.55) PSMD14ALDH1A1TDP1GAA
SCHEMBL9813540 0.91 PSMD14 (0.60) PSMD14ALDH1A1TDP1POLBKMT2A
SCHEMBL10853625 0.91 PSMD14 (0.60) PSMD14ALDH1A1TDP1POLBKMT2A
SCHEMBL9813610 0.90 ALDH1A1 (0.71) PSMD14ALDH1A1TDP1POLBKMT2A
SCHEMBL9813617 0.90 ALDH1A1 (0.71) PSMD14ALDH1A1TDP1POLBKMT2A
SCHEMBL9813600 0.88 PSMD14 (0.51) PSMD14ALDH1A1TDP1POLBKMT2A
SCHEMBL9813607 0.88 PSMD14 (0.51) PSMD14ALDH1A1TDP1POLBKMT2A
SCHEMBL9813567 0.87 ALDH1A1 (0.54) PSMD14ALDH1A1TDP1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0124911-B1 4-OXO-THIAZOLIDIN-2-YLIDEN-ACETAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM ILLNESSES CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-07-31 — — EP claimed
US-4563471-A CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 1986-01-07 — — US claimed
EP-0124911-A2 4-Oxo-thiazolidin-2-yliden-acetamide derivatives, process for their preparation, and medicaments for the treatment of central nervous system illnesses containing them GÖDECKE AKTIENGESELLSCHAFT (DE) 1984-11-14 — — EP claimed
EP-0124911-B1 4-OXO-THIAZOLIDIN-2-YLIDEN-ACETAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM ILLNESSES CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-07-31 — — EP disclosed
US-4563471-A CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 1986-01-07 — — US disclosed
EP-0124911-A2 4-Oxo-thiazolidin-2-yliden-acetamide derivatives, process for their preparation, and medicaments for the treatment of central nervous system illnesses containing them GÖDECKE AKTIENGESELLSCHAFT (DE) 1984-11-14 — — EP disclosed
Send feedback